Domestic Vaccine Production Recommences

South Africa is poised to regain the capacity to manufacture vaccines following an announcement by public-private partnership (PPP) the Biovac Institute that it has begun production of small quantities of hepatitis B vaccine for validation and testing by the Medicines Control Council (MCC). BMI expects approval to be put onto a fast track given the strategic value of local vaccine manufacturing capacity, so commercial production could begin before the end of

To read the full article, please choose one of the following options: